Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
2011 · New England Journal of Medicine · 751 citations
https://doi.org/10.1056/nejmoa1109719
P
Philip E. Aylward
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
337
Papers
24.0K
Citations
67
h-index
183
i10-index
Philip E. Aylward is an academic researcher from South Australian Health and Medical Research Institute. The author has contributed to research in topics: Acute Myocardial Infarction Research & Antiplatelet Therapy and Cardiovascular Diseases & Cardiac Imaging and Diagnostics. The author has an h-index of 67, co-authored 287 publications.
ORCID: 0000-0002-5358-8552Papers by this author
worksEffect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
2020 · Journal of the American College of Cardiology · 545 citations
https://doi.org/10.1016/j.jacc.2019.10.057
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction
2024 · New England Journal of Medicine · 103 citations
https://doi.org/10.1056/nejmoa2400969
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial
2014 · European Heart Journal · 101 citations
https://doi.org/10.1093/eurheartj/ehu177
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI
2024 · Journal of the American College of Cardiology · 28 citations
https://doi.org/10.1016/j.jacc.2024.03.396
Developing a national implementation strategy for enhancing the detection of familial hypercholesterolemia: An Australian experience
2025 · Journal of clinical lipidology · 3 citations
https://doi.org/10.1016/j.jacl.2025.03.004
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat